A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.

Kitas, George D

A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis. [electronic resource] - Arthritis & rheumatology (Hoboken, N.J.) 09 2019 - 1437-1449 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

2326-5205

10.1002/art.40892 doi


Aged
Anticholesteremic Agents--therapeutic use
Arthritis, Rheumatoid--blood
Atorvastatin--therapeutic use
Cardiovascular Diseases--etiology
Cholesterol, LDL--blood
Double-Blind Method
Female
Humans
Male
Middle Aged
Primary Prevention--methods
Proportional Hazards Models
Treatment Outcome